Haleon plc American Depositary Shares (Each representing two Ordinary Shares) vs Lithium Americas Corp — how do they compare? Haleon plc American Depositary Shares (Each representing two Ordinary Shares) trades at $9.28 (market cap $40.01B), while Lithium Americas Corp trades at $2.35 (market cap $850.38M). The key difference: Haleon plc American Depositary Shares (Each representing two Ordinary Shares) is far larger — about 47× Lithium Americas Corp's market cap, and Haleon plc American Depositary Shares (Each representing two Ordinary Shares) pays a 2.14% dividend while Lithium Americas Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Haleon plc American Depositary Shares (Each representing two Ordinary Shares) for 0 Days and Lithium Americas Corp for 27 Days on average.
| HLN | LAC | |
|---|---|---|
Market Cap | $40.01B | $850.38M |
Volume | 19,985,935 | 8,804,637 |
Sector | Health | Basic Materials |
52-Week High | $11.27 | $10.05 |
52-Week Low | $8.70 | $2.36 |
Typical Hold Time | 0 Days | 27 Days |
Enterprise Value | $49.79B | $1.19B |
Dividend Yield | 2.14% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Lithium Americas (LAC) trades at $2.41, down 5.12% in the last session, reflecting ongoing market pressure despite recent earnings beats. The company shows negative profitability metrics with a -9.56% ROE and -$122.09M net income for 2025, though it maintains strong financing activity with $1.14B in cash flow from financing. Technical indicators show a bearish trend with moving averages signaling sell pressure, while oscillators suggest potential oversold conditions. Recent news highlights construction progress at Thacker Pass as a key development catalyst.
The investment outlook remains speculative with significant execution risk at Thacker Pass offset by analyst optimism (46.67% buy rating) and a $4.00 consensus price target representing 66% upside. Key risks include lithium price volatility, project execution challenges, and sustained negative cash flow from operations. The stock's current valuation at 0.6x book value may attract value investors betting on successful project commercialization.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Haleon is a consumer healthcare company offering over-the-counter medicines, oral health products, vitamins, and wellness brands.
Read more on HLN →Lithium Americas is a resource company focused on developing the Thacker Pass project in Nevada, the largest known lithium resource in the US. It aims to become a major supplier for the electric vehicle battery market.
Read more on LAC →